Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

nuclear imaging

  • Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade
    Open Access
    Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade
    Quentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, Wout de Mey, Thomas Ertveldt, Cleo Goyvaerts, Geert Raes, Kris Thielemans, Marleen Keyaerts, Nick Devoogdt and Karine Breckpot
    Journal of Nuclear Medicine November 1, 2021, 62 (11) 1638-1644; DOI: https://doi.org/10.2967/jnumed.120.258871
  • You have access
    Repurposing Molecular Imaging and Sensing for Cancer Image–Guided Surgery
    Suman B. Mondal, Christine M. O’Brien, Kevin Bishop, Ryan C. Fields, Julie A. Margenthaler and Samuel Achilefu
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1113-1122; DOI: https://doi.org/10.2967/jnumed.118.220426
  • You have access
    Preclinical Evaluation of Mesothelin-Specific Ligands for SPECT Imaging of Triple-Negative Breast Cancer
    Christopher Montemagno, Sandrine Bacot, Mitra Ahmadi, Brigitte Kerfelec, Daniel Baty, Marlene Debiossat, Audrey Soubies, Pascale Perret, Laurent Riou, Daniel Fagret, Alexis Broisat and Catherine Ghezzi
    Journal of Nuclear Medicine July 1, 2018, 59 (7) 1056-1062; DOI: https://doi.org/10.2967/jnumed.117.203489
  • You have access
    Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features
    John C. Stendahl and Albert J. Sinusas
    Journal of Nuclear Medicine October 1, 2015, 56 (10) 1469-1475; DOI: https://doi.org/10.2967/jnumed.115.160994
  • You have access
    Preclinical Evaluation of a Radioiodinated Fully Human Antibody for In Vivo Imaging of Vascular Adhesion Protein-1–Positive Vasculature in Inflammation
    Anu Autio, Petri J. Vainio, Sami Suilamo, Antti Mali, Jani Vainio, Tiina Saanijoki, Tommi Noponen, Helena Ahtinen, Pauliina Luoto, Mika Teräs, Sirpa Jalkanen and Anne Roivainen
    Journal of Nuclear Medicine August 1, 2013, 54 (8) 1315-1319; DOI: https://doi.org/10.2967/jnumed.113.120295
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire